Both in Pharmaceuticals
IDEAYA Biosciences vs Organon &
Over the past year IDYA returned +39.2% and OGN returned +32.8%; their daily moves had a correlation of -0.07.
IDYA +39.2% OGN +32.8%Growth of $1, one year, split-adjusted
| Metric | IDYA | OGN |
|---|---|---|
| Price | $37.86 | $13.74 |
| Market cap | $3.65B | $3.61B |
| Today | −0.94% | +0.07% |
| 1 month | −5.6% | −0.1% |
| 6 months | +20.4% | +141.1% |
| Year to date | +9.5% | +91.6% |
| 1 year | +41.1% | +34.6% |
| Revenue growth (YoY) | — | −2.3% |
| Gross margin | 100.0% | 54.4% |
| Net margin | −1269.6% | 6.9% |
| P/E (TTM) | — | 17.3× |
| Price / sales | 15.6× | 0.6× |
| Net cash | $829.0M | -$7.42B |
| Dividend yield | — | 0.58% |
| Volatility (60d) | 35.7% | 2.8% |
| Short % of float | 11.4% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).